This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Histology

Authoring team

The classical cell seen on histological examination is the Reed-Sternberg cell, which is a necessary, but not a sufficient element, for the diagnosis of Hodgkin's disease. Other cells seen in diseased tissue include histiocytes, lymphocytes, plasma cells, eosinophils and fibroblasts.

Currently histologic classification for adult Hodgkin lymphoma is carried out according to the World Health Organization (WHO) modification of the Revised European-American Lymphoma (REAL) classification (WHO/REAL classification)

  • classical Hodgkin's disease – is further divided into four types:
    • lymphocyte predominant:
      • thought to be a clinically distinct B cell lymphoma
      • often only affects a single lymph node
    • nodular sclerosis:
      • accounts for 70-80% of Hodgkin's disease
      • classically a disease of young women
      • presents with cervical and mediastinal lymphadenopathy
    • mixed cellularity:
      • commonly found in elderly people
      • often widespread at presentation
    • lymphocyte depleted:
      • more prevalent in immunocompromised patients
      • more commonly seen in developing countries where it has a strong association with EBV infection (1,2)
  • nodular lymphocyte predominant (NLPHL)
    • HRS cells are not present
    • has a risk of transformation to high grade non-Hodgkin lymphoma
    • managed differently from classical HL

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.